SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Sagimet Biosciences Inc.
Date: May 7, 2025 · CIK: 0001400118 · Accession: 0000000000-25-004809

Financial Reporting Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-41742

Date
May 7, 2025
Author
Finance
Form
UPLOAD
Company
Sagimet Biosciences Inc.

Letter

Re: Sagimet Biosciences Inc. Form 10-K for Fiscal Year Ended December 31, 2024 File No. 001-41742 Dear Thierry Chauche:

May 7, 2025

Thierry Chauche Principal Financial and Accounting Officer Sagimet Biosciences Inc. 155 Bovet Road, Suite 303 San Mateo, California 94402

We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,
Division of Corporation
Finance
Office of Life Sciences

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 May 7, 2025

Thierry Chauche
Principal Financial and Accounting Officer
Sagimet Biosciences Inc.
155 Bovet Road, Suite 303
San Mateo, California 94402

 Re: Sagimet Biosciences Inc.
 Form 10-K for Fiscal Year Ended December 31, 2024
 File No. 001-41742
Dear Thierry Chauche:

 We have completed our review of your filing. We remind you that the
company and
its management are responsible for the accuracy and adequacy of their
disclosures,
notwithstanding any review, comments, action or absence of action by the staff.

 Sincerely,

 Division of Corporation
Finance
 Office of Life Sciences
</TEXT>
</DOCUMENT>